pI: 6.1208 |
Length (AA): 909 |
MW (Da): 105537 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 14 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
12 | 300 | 2buj (A) | 8 | 298 | 24.00 | 0 | 1 | 0.71 | -1.52 |
16 | 382 | 2b9h (A) | 6 | 350 | 24.00 | 0 | 1 | 0.65 | -0.56 |
489 | 600 | 1ktm (A) | 921 | 1036 | 13.00 | 0.000000012 | 0.05 | 0.22 | -0.24 |
33 | 516 | 3q5i (A) | 64 | 509 | 31.00 | 0.000000000017 | 1 | 0.567553 | 0.89 |
258 | 758 | 4h5y (A) | 60 | 526 | 24.00 | 0.28 | 0.7 | 0.635255 | 0.7 |
622 | 800 | 4u5a (C) | 48 | 239 | 21.00 | 0.45 | 0.02 | 0.34712 | -0.14 |
643 | 784 | 4ux7 (A) | 81 | 218 | 32.00 | 0.9 | 0.18 | 0.206016 | 1 |
12 | 296 | 4w9w (A) | 39 | 319 | 34.00 | 0 | 1 | 0.807229 | -0.9 |
25 | 548 | 4e3c (A) | 16 | 614 | 18.00 | 0 | 1 | 0.604304 | 0.81 |
27 | 232 | 4krd (A) | 11 | 199 | 39.00 | 0.0000000098 | 1 | 0.47666 | 0.21 |
68 | 282 | 1phk (A) | 72 | 275 | 31.00 | 0.00000071 | 1 | 0.525864 | -0.28 |
71 | 527 | 4ci6 (B) | 179 | 642 | 17.00 | 0.0002 | 1 | 0.566341 | 0.43 |
142 | 245 | 3a99 (A) | 157 | 245 | 37.00 | 0.15 | 0.22 | 0.136014 | 1.18 |
346 | 539 | 4f61 (I) | 16 | 229 | 21.00 | 0.19 | 0.01 | 0.354055 | -0.39 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, sporozoite, Sporozoite. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, gametocyte, late schizont, Female Gametocyte. | Otto TD PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, early schizont, Male Gametocyte. | Otto TD PlasmoDB Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Oocyst, Ring. | Zanghi G |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Ortholog group members (OG5_127425)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G32850 | protein kinase superfamily protein |
Brugia malayi | Bm1_37065 | Protein kinase domain containing protein |
Candida albicans | CaO19.5357 | Ark-family kinase-like protein |
Candida albicans | CaO19.2605 | possible serine/threonine kinase |
Candida albicans | CaO19.10136 | possible serine/threonine kinase |
Candida albicans | CaO19.12817 | Ark-family kinase-like protein |
Caenorhabditis elegans | CELE_F35G12.3 | Protein SEL-5, isoform B |
Dictyostelium discoideum | DDB_G0276461 | NAK family protein kinase |
Dictyostelium discoideum | DDB_G0280111 | NAK family protein kinase |
Drosophila melanogaster | Dmel_CG10637 | Numb-associated kinase |
Echinococcus granulosus | EgrG_000165700 | AP2 associated protein kinase 1 |
Entamoeba histolytica | EHI_103290 | protein kinase, putative |
Entamoeba histolytica | EHI_127410 | protein kinase domain containing protein |
Echinococcus multilocularis | EmuJ_000165700 | AP2 associated protein kinase 1 |
Giardia lamblia | GL50803_12223 | Kinase, NAK |
Homo sapiens | ENSG00000138756 | BMP2 inducible kinase |
Homo sapiens | ENSG00000115977 | AP2 associated kinase 1 |
Leishmania braziliensis | LbrM.20.0110 | protein kinase, putative |
Leishmania donovani | LdBPK_340030.1 | protein kinase, putative |
Leishmania infantum | LinJ.34.0030 | protein kinase, putative |
Leishmania major | LmjF.34.0030 | protein kinase, putative |
Leishmania mexicana | LmxM.33.0030 | protein kinase, putative |
Loa Loa (eye worm) | LOAG_05227 | NAK/BIKE protein kinase |
Mus musculus | ensembl-mmu:ENSMUSG00000034663 | BMP2 inducible kinase |
Mus musculus | 102637099 | uncharacterized LOC102637099 |
Mus musculus | ENSMUSG00000057230 | AP2 associated kinase 1 |
Neospora caninum | NCLIV_050490 | hypothetical protein |
Oryza sativa | 4346601 | Os09g0279100 |
Plasmodium berghei | PBANKA_1460500 | serine/threonine protein kinase, putative |
Plasmodium falciparum | PF3D7_1247500 | serine/threonine protein kinase, putative |
Plasmodium knowlesi | PKNH_1467200 | serine/threonine protein kinase, putative |
Plasmodium vivax | PVX_101265 | cyclin g-associated kinase, putative |
Plasmodium yoelii | PY06849 | hypothetical protein |
Saccharomyces cerevisiae | YBR059C | Akl1p |
Saccharomyces cerevisiae | YIL095W | Prk1p |
Saccharomyces cerevisiae | YNL020C | Ark1p |
Schistosoma japonicum | Sjp_0086670 | ko:K08854 BMP2 inducible kinase, putative |
Schistosoma japonicum | Sjp_0107280 | AP2-associated protein kinase 1, putative |
Schistosoma mansoni | Smp_176750 | serine/threonine protein kinase |
Schmidtea mediterranea | mk4.015925.00 | |
Schmidtea mediterranea | mk4.000160.18 | |
Schmidtea mediterranea | mk4.006232.02 | |
Schmidtea mediterranea | mk4.006232.01 | |
Trypanosoma cruzi | TcCLB.506953.30 | serine/threonine-protein kinase NAK, putative |
Trypanosoma cruzi | TcCLB.509287.20 | serine/threonine-protein kinase NAK, putative |
Toxoplasma gondii | TGME49_236240 | Tyrosine kinase-like (TKL) protein |
Trichomonas vaginalis | TVAG_144060 | CAMK family protein kinase |
Trichomonas vaginalis | TVAG_475520 | CAMK family protein kinase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_F35G12.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
YNL020C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1460500 | Plasmodium berghei | Slow | plasmo |
TGME49_236240 | Toxoplasma gondii | Essentiality uncertain | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.7
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | BMP2 inducible kinase | Compounds | References |
Homo sapiens | AP2 associated kinase 1 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Oryctolagus cuniculus | Cyclin-dependent kinase 4 | 189 aa | 25.3% | 178 aa | Compounds | References |
56 literature references were collected for this gene.